The expression of CYP2W1 in colorectal primary tumors, corresponding lymph node metastases and liver metastases

Acta Oncologica

Volumn 53, Issue 7, 2014, Pages 885-891

  Stenstedt, Kristina ^a,b   Hallstrom, Marja ^b   Lédel, Frida ^a,b   Ragnhammar, Peter ^b   Ingelman Sundberg, Magnus ^b   Johansson, Inger ^b   Edler, David ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2W1; UNCLASSIFIED DRUG; CYP2W1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; COLORECTAL LIVER METASTASIS; COLORECTAL SURGERY; FOLLOW UP; HUMAN TISSUE; LIVER RESECTION; LYMPH NODE DISSECTION; MIDDLE AGED; AGED; COHORT ANALYSIS; COLORECTAL NEOPLASMS; LIVER TUMOR; LYMPH NODE; METABOLISM; MORTALITY; PATHOLOGY; SECONDARY; SURVIVAL;

AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 84903273821     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.887224     Document Type: Article

References (28)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Sjovall A, Jarv V, Blomqvist L, Singnomklao T, Cedermark B, Glimelius B, et al. The potential for improved outcome in patients with hepatic metastases from colon cancer: A population- based study. Eur J Surg Oncol 2004; 30: 834-41.
3. Maringe C, Walters S, Rachet B, Butler J, Fields T, Finan P, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000-2007. Acta Oncol 2013; 52: 919-32.
4. National follow up colon cancer 2011. [ cited 2013 Aug 19]. Available from: www.cancercentrum.se/Global/Diagnoser/ kolorektal/rapporter/colon2011.pdf.
5. National follow-up rectal cancer 2 013 [ cited 2013 Aug 19]. Available from: www.cancercentrum.se/Global/Diagnoser/ kolorektal/rapporter/rekti2011- 120629.pdf.
6. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, S mith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62: 220-41.
7. Mancini R, Ettorre G, Vennarecci G, Sperduti I, Garufi C, Esposito A, et al. Personal experience on treatment of colorectal liver metastases: A multidisciplinary approach. J Exp Clin Cancer Res 2003; 22(4 Suppl): 213-7.
8. Norstein J, Silen W. Natural history of liver metastases from colorectal carcinoma. J Gastrointest Surg 1997; 1: 398-407.
9. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009; 27: 3677-83.
10. Abdalla E K, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 2006; 13: 1271-80.
11. Morris EJ, Forman D, Thomas JD, Quirke P, Taylor EF, Fairley L, et al. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 2010; 97: 1110-8.
12. Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al. Survival after liver resection in metastatic colorectal cancer: Review and meta-analysis of prognostic factors. Clin Epidemiol 2012; 4: 283-301.
13. Edler D, Stenstedt K, Ohrling K, Hallstrom M, Karlgren M, Ingelman-Sundberg M, et al. The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer-a pilot study. Eur J Cancer 2009; 45: 705-12.
14. Stenstedt K, Hallstrom M, Johansson I, Ingelman-Sundberg M, Ragnhammar P, Edler D. The expression of CYP2W1: A prognostic marker in colon cancer. Anticancer Res 2012; 32: 3869-74.
15. Karlgren M, Gomez A, Stark K, Svard J, Rodriguez-Antona C, Oliw E, et al. Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1. Biochem Biophys Res Commun 2006; 341: 451-8.
16. Wu Z L, Sohl C D, Shimada T, Guengerich F P. Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol Pharmacol 2006; 69: 2007-14.
17. Gomez A, Karlgren M, Edler D, Bernal ML, Mkrtchian S, Ingelman-Sundberg M. Expression of CYP2W1 in colon tumors: Regulation by gene methylation. Pharmacogenomics 2007; 8: 1315-25.
18. Nishida C R, Lee M, de Montellano P R. Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1. Mol Pharmacol 2010; 78: 497-502.
19. Xiao Y, Guengerich FP. Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids. J Lipid Res 2012; 53: 1610-7.
20. Travica S, Pors K, Loadman P M, Shnyder S D, Johansson I, Alandas MN, et al. Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxins. Clin Cancer Res 2013; 19: 2952-61.
21. Habermann J K, Paulsen U, Roblick U J, Upender M B, McShane LM, Korn EL, et al. Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer 2007; 46: 10-26.
22. Nambiar P R, Gupta R R, Misra V. An "Omics" based survey of human colon cancer. Mutation research 2010; 693: 3-18.
23. Jones S, Chen W D, Parmigiani G, Diehl F, Beerenwinkel N, Antal T, et al. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A 2008; 105: 4283-8.
24. Ramaswamy S, Ross K N, Lander E S, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33: 49-54.
25. Fearon E R, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
26. Valastyan S, Weinberg RA. Tumor metastasis: Molecular insights and evolving paradigms. Cell 2011; 147: 275-92.
27. Dittmar T, Heyder C, Gloria-Maercker E, Hatzmann W, Zanker KS. Adhesion molecules and chemokines: The navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner. Clin Exp Metastasis 2008; 25: 11-32.
28. Gomez A, Nekvindova J, Travica S, Lee M Y, Johansson I, Edler D, et al. Colorectal cancer-specific cytochrome P450 2W1: Intracellular localization, glycosylation, and catalytic activity. Mol Pharmacol 2010; 78: 1004-11.